NCT06062420
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06062420
Title A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | ROU | POL | NOR | ITA | HUN | GRC | FRA | FIN | ESP | DNK | DEU | CAN | BRA | ARG

Facility Status City State Zip Country Details
GSK Investigational Site New Haven Connecticut 06511 United States Details
GSK Investigational Site Iowa City Iowa 52242 United States Details
GSK Investigational Site St Louis Missouri 63021 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site Capital Federal C1181ACH Argentina Details
GSK Investigational Site Ciudad Autonoma de Bueno C1056ABI Argentina Details
GSK Investigational Site Córdoba 5000 Argentina Details
GSK Investigational Site Florida B1602DQD Argentina Details
GSK Investigational Site Mendoza M5500AYB Argentina Details
GSK Investigational Site San Juan 5400 Argentina Details
GSK Investigational Site Santa Fe 3000 Argentina Details
GSK Investigational Site Santo André 09060-650 Brazil Details
GSK Investigational Site São Paulo 01221-020 Brazil Details
GSK Investigational Site São Paulo 01246-000 Brazil Details
GSK Investigational Site Calgary Alberta T2N 5G2 Canada Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Toronto Ontario M4N 3M5 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Herlev Denmark Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Bordeaux 33075 France Details
GSK Investigational Site Caen 14075 France Details
GSK Investigational Site Marseille 13005 France Details
GSK Investigational Site Paris 75005 France Details
GSK Investigational Site Rouen 76038 France Details
GSK Investigational Site Villejuif 94805 France Details
GSK Investigational Site Aachen 52074 Germany Details
GSK Investigational Site Berlin 12200 Germany Details
GSK Investigational Site Essen 45122 Germany Details
GSK Investigational Site Frankfurt 60488 Germany Details
GSK Investigational Site Giessen 35392 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Leipzig 04103 Germany Details
GSK Investigational Site Regensburg 93053 Germany Details
GSK Investigational Site Ulm 89075 Germany Details
GSK Investigational Site Haidari - Athens 12462 Greece Details
GSK Investigational Site Marousi Greece Details
GSK Investigational Site Thessaloniki 55236 Greece Details
GSK Investigational Site Győr 9024 Hungary Details
GSK Investigational Site Kecskemét 6000 Hungary Details
GSK Investigational Site Nyíregyháza 4400 Hungary Details
GSK Investigational Site Pécs 7624 Hungary Details
GSK Investigational Site Bari 70124 Italy Details
GSK Investigational Site Bologna 40139 Italy Details
GSK Investigational Site Florence 50134 Italy Details
GSK Investigational Site Genova 16132 Italy Details
GSK Investigational Site Milan 20133 Italy Details
GSK Investigational Site Napoli 80131 Italy Details
GSK Investigational Site Novara 28100 Italy Details
GSK Investigational Site Padua 35128 Italy Details
GSK Investigational Site Roma 00144 Italy Details
GSK Investigational Site Roma 00168 Italy Details
GSK Investigational Site Rozzano MI 20089 Italy Details
GSK Investigational Site Aichi 464-8681 Japan Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Hyōgo 650-0017 Japan Details
GSK Investigational Site Osaka 541-8567 Japan Details
GSK Investigational Site Saitama 350-1298 Japan Details
GSK Investigational Site Shizuoka 411-8777 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Oslo 0379 Norway Details
GSK Investigational Site Bielsko-Biala 43-300 Poland Details
GSK Investigational Site Gliwice 44-102 Poland Details
GSK Investigational Site Katowice 40-514 Poland Details
GSK Investigational Site Krakow 31-826 Poland Details
GSK Investigational Site Przemyśl 37-700 Poland Details
GSK Investigational Site Siedlce 08-110 Poland Details
GSK Investigational Site Warsaw 04-141 Poland Details
GSK Investigational Site Almada 2801-951 Portugal Details
GSK Investigational Site Lisbon 1649-035 Portugal Details
GSK Investigational Site Porto 4099-001 Portugal Details
GSK Investigational Site Porto 4200-072 Portugal Details
GSK Investigational Site Brasov 500283 Romania Details
GSK Investigational Site Bucharest 013823 Romania Details
GSK Investigational Site Bucharest 020142 Romania Details
GSK Investigational Site Bucharest 022328 Romania Details
GSK Investigational Site Bucharest 030171 Romania Details
GSK Investigational Site Bucharest 30463 Romania Details
GSK Investigational Site Craiova 200508 Romania Details
GSK Investigational Site Craiova 200542 Romania Details
GSK Investigational Site Floreşti 407280 Romania Details
GSK Investigational Site Iași 700483 Romania Details
GSK Investigational Site Oradea 410469 Romania Details
GSK Investigational Site Piteşti 110283 Romania Details
GSK Investigational Site Suceava 720214 Romania Details
GSK Investigational Site Daegu 42601 South Korea Details
GSK Investigational Site Seongnam-si Gyeonggi-do 13620 South Korea Details
GSK Investigational Site Seoul 03722 South Korea Details
GSK Investigational Site Seoul 138-736 South Korea Details
GSK Investigational Site Suwon Kyunggi-do 443-721 South Korea Details
GSK Investigational Site Barcelona 08023 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08907 Spain Details
GSK Investigational Site Jaén 23007 Spain Details
GSK Investigational Site Madrid 28010 Spain Details
GSK Investigational Site Madrid 28034 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Pozuelo de AlarcOn Madr 28223 Spain Details
GSK Investigational Site Salamanca 37007 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Zaragoza 50009 Spain Details
GSK Investigational Site Changhua 500 Taiwan Details
GSK Investigational Site Tainan 704 Taiwan Details
GSK Investigational Site Taipei 10002 Taiwan Details
GSK Investigational Site Taipei 11217 Taiwan Details
GSK Investigational Site Ankara 06100 Turkey (Türkiye) Details
GSK Investigational Site Istanbul 34662 Turkey (Türkiye) Details
GSK Investigational Site Izmir 35040 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field